Compliance, Regulatory Requirements
23 Jan 2025
compliance, regulations, irs, paperwork reduction, branded prescription drugs
📄IRS Seeks Comments on Information Collection for Branded Drugs Regulations
The Internal Revenue Service, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on continuing information collections, as required by the Paperwork Reduction Act of 1995. The IRS is soliciting comments concerning information collection requirements related to branded prescription drugs.
Learn More